A randomized, controlled trial of disability prevention in frail older patients screened in primary care

The FRASI study. Design and baseline evaluation

Stefania Bandinelli, Fulvio Lauretani, Vittorio Boscherini, Francesca Gandi, Martina Pozzi, Anna Maria Corsi, Benedetta Bartali, Raffaello Molino Lova, Jack M. Guralnik, Luigi Ferrucci

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background and aims: We describe the enrollment and intervention phases of FRASI (FRAilty, Screening and Intervention), a randomized controlled trial aimed at preventing ADL disability in frail older persons screened in primary care. Methods: Patients, 70-85 years old, non-disabled and non-cognitively impaired, were screened for frailty (score ≤9 on the Short Physical Performance Battery, SPPB) during primary care visits. Of 447 eligible persons, 410 came to the study clinic and 251 were randomized into treatment (n=126) and control groups (n=125). The active group received an intensive medical intervention, and sixteen 90-minute supervised exercise sessions over 8 weeks. The primary outcome was time to ADL disability onset or death in the 12-month period after study enrollment. Results: The two study arms were similar for demographics, cognitive function, physical function and health status. Compared with a population-based sample selected according to FRASI inclusion criteria except SPPB score, FRASI participants had significantly worse health and functional status. Restricting the comparison to persons with SPPB ≤9, all differences disappeared. The 99 participants (78.6% of 126) who completed the intervention participated in a mean of 15.3±1.6 exercise sessions. Conclusions: Screening in primary care for non-disabled, older persons with SPPB ≤9 yields individuals with substantial morbidity, impairments and functional limitations that can be successfully involved in an intensive medical and exercise intervention. Whether such an intervention effectively prevents new disability remains to be confirmed.

Original languageEnglish
Pages (from-to)359-366
Number of pages8
JournalAging clinical and experimental research
Volume18
Issue number5
Publication statusPublished - Oct 2006

Fingerprint

Primary Health Care
Randomized Controlled Trials
Exercise
Activities of Daily Living
Health Status
Cognition
Demography
Morbidity
Control Groups
Population
Therapeutics

Keywords

  • Disability
  • Frailty
  • FRASI
  • Prevention

ASJC Scopus subject areas

  • Ageing

Cite this

A randomized, controlled trial of disability prevention in frail older patients screened in primary care : The FRASI study. Design and baseline evaluation. / Bandinelli, Stefania; Lauretani, Fulvio; Boscherini, Vittorio; Gandi, Francesca; Pozzi, Martina; Corsi, Anna Maria; Bartali, Benedetta; Lova, Raffaello Molino; Guralnik, Jack M.; Ferrucci, Luigi.

In: Aging clinical and experimental research, Vol. 18, No. 5, 10.2006, p. 359-366.

Research output: Contribution to journalArticle

Bandinelli, S, Lauretani, F, Boscherini, V, Gandi, F, Pozzi, M, Corsi, AM, Bartali, B, Lova, RM, Guralnik, JM & Ferrucci, L 2006, 'A randomized, controlled trial of disability prevention in frail older patients screened in primary care: The FRASI study. Design and baseline evaluation', Aging clinical and experimental research, vol. 18, no. 5, pp. 359-366.
Bandinelli, Stefania ; Lauretani, Fulvio ; Boscherini, Vittorio ; Gandi, Francesca ; Pozzi, Martina ; Corsi, Anna Maria ; Bartali, Benedetta ; Lova, Raffaello Molino ; Guralnik, Jack M. ; Ferrucci, Luigi. / A randomized, controlled trial of disability prevention in frail older patients screened in primary care : The FRASI study. Design and baseline evaluation. In: Aging clinical and experimental research. 2006 ; Vol. 18, No. 5. pp. 359-366.
@article{2e26bea57e6c44b8bd980896998f6e53,
title = "A randomized, controlled trial of disability prevention in frail older patients screened in primary care: The FRASI study. Design and baseline evaluation",
abstract = "Background and aims: We describe the enrollment and intervention phases of FRASI (FRAilty, Screening and Intervention), a randomized controlled trial aimed at preventing ADL disability in frail older persons screened in primary care. Methods: Patients, 70-85 years old, non-disabled and non-cognitively impaired, were screened for frailty (score ≤9 on the Short Physical Performance Battery, SPPB) during primary care visits. Of 447 eligible persons, 410 came to the study clinic and 251 were randomized into treatment (n=126) and control groups (n=125). The active group received an intensive medical intervention, and sixteen 90-minute supervised exercise sessions over 8 weeks. The primary outcome was time to ADL disability onset or death in the 12-month period after study enrollment. Results: The two study arms were similar for demographics, cognitive function, physical function and health status. Compared with a population-based sample selected according to FRASI inclusion criteria except SPPB score, FRASI participants had significantly worse health and functional status. Restricting the comparison to persons with SPPB ≤9, all differences disappeared. The 99 participants (78.6{\%} of 126) who completed the intervention participated in a mean of 15.3±1.6 exercise sessions. Conclusions: Screening in primary care for non-disabled, older persons with SPPB ≤9 yields individuals with substantial morbidity, impairments and functional limitations that can be successfully involved in an intensive medical and exercise intervention. Whether such an intervention effectively prevents new disability remains to be confirmed.",
keywords = "Disability, Frailty, FRASI, Prevention",
author = "Stefania Bandinelli and Fulvio Lauretani and Vittorio Boscherini and Francesca Gandi and Martina Pozzi and Corsi, {Anna Maria} and Benedetta Bartali and Lova, {Raffaello Molino} and Guralnik, {Jack M.} and Luigi Ferrucci",
year = "2006",
month = "10",
language = "English",
volume = "18",
pages = "359--366",
journal = "Aging clinical and experimental research",
issn = "1594-0667",
publisher = "Springer International Publishing AG",
number = "5",

}

TY - JOUR

T1 - A randomized, controlled trial of disability prevention in frail older patients screened in primary care

T2 - The FRASI study. Design and baseline evaluation

AU - Bandinelli, Stefania

AU - Lauretani, Fulvio

AU - Boscherini, Vittorio

AU - Gandi, Francesca

AU - Pozzi, Martina

AU - Corsi, Anna Maria

AU - Bartali, Benedetta

AU - Lova, Raffaello Molino

AU - Guralnik, Jack M.

AU - Ferrucci, Luigi

PY - 2006/10

Y1 - 2006/10

N2 - Background and aims: We describe the enrollment and intervention phases of FRASI (FRAilty, Screening and Intervention), a randomized controlled trial aimed at preventing ADL disability in frail older persons screened in primary care. Methods: Patients, 70-85 years old, non-disabled and non-cognitively impaired, were screened for frailty (score ≤9 on the Short Physical Performance Battery, SPPB) during primary care visits. Of 447 eligible persons, 410 came to the study clinic and 251 were randomized into treatment (n=126) and control groups (n=125). The active group received an intensive medical intervention, and sixteen 90-minute supervised exercise sessions over 8 weeks. The primary outcome was time to ADL disability onset or death in the 12-month period after study enrollment. Results: The two study arms were similar for demographics, cognitive function, physical function and health status. Compared with a population-based sample selected according to FRASI inclusion criteria except SPPB score, FRASI participants had significantly worse health and functional status. Restricting the comparison to persons with SPPB ≤9, all differences disappeared. The 99 participants (78.6% of 126) who completed the intervention participated in a mean of 15.3±1.6 exercise sessions. Conclusions: Screening in primary care for non-disabled, older persons with SPPB ≤9 yields individuals with substantial morbidity, impairments and functional limitations that can be successfully involved in an intensive medical and exercise intervention. Whether such an intervention effectively prevents new disability remains to be confirmed.

AB - Background and aims: We describe the enrollment and intervention phases of FRASI (FRAilty, Screening and Intervention), a randomized controlled trial aimed at preventing ADL disability in frail older persons screened in primary care. Methods: Patients, 70-85 years old, non-disabled and non-cognitively impaired, were screened for frailty (score ≤9 on the Short Physical Performance Battery, SPPB) during primary care visits. Of 447 eligible persons, 410 came to the study clinic and 251 were randomized into treatment (n=126) and control groups (n=125). The active group received an intensive medical intervention, and sixteen 90-minute supervised exercise sessions over 8 weeks. The primary outcome was time to ADL disability onset or death in the 12-month period after study enrollment. Results: The two study arms were similar for demographics, cognitive function, physical function and health status. Compared with a population-based sample selected according to FRASI inclusion criteria except SPPB score, FRASI participants had significantly worse health and functional status. Restricting the comparison to persons with SPPB ≤9, all differences disappeared. The 99 participants (78.6% of 126) who completed the intervention participated in a mean of 15.3±1.6 exercise sessions. Conclusions: Screening in primary care for non-disabled, older persons with SPPB ≤9 yields individuals with substantial morbidity, impairments and functional limitations that can be successfully involved in an intensive medical and exercise intervention. Whether such an intervention effectively prevents new disability remains to be confirmed.

KW - Disability

KW - Frailty

KW - FRASI

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=33846442413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846442413&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 359

EP - 366

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

SN - 1594-0667

IS - 5

ER -